MAP2 and Global developmental delay: The case of our patient affected by developmental delay, epilepsy, neurocognitive, and behavioral abnormalities is fitting to the hypothesis that MAP2 is one of the candidate genes, as our patient’s microdeletion is the smallest one described in the literature so far spanning MAP2 amongst other genes.